AZITHROMYCIN TABLETS

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-22-D-0143

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

Princeton, New Jersey, UNITED STATES

SourceSAM
Documents4
The Defense Logistics Agency (DLA) Troop Support, operating under the Department of Defense, has issued an award notice for a national contract pertaining to the supply of Azithromycin Tablets. This procurement, identified by contract number SPE2D2-22-D-0143, falls under the North American Industry Classification System (NAICS) code 325412, which covers Pharmaceutical Preparation Manufacturing. The associated Product Service Code is 6505, indicating a focus on drugs and biologicals. The primary objective of this contract is to ensure a reliable and consistent supply of Azithromycin Tablets, a critical pharmaceutical product, to support the operational and healthcare needs of the Department of Defense and its associated entities. The scope of the contract encompasses the manufacturing and delivery of these tablets, with the place of performance specified as Princeton, New Jersey, United States. This location is likely significant for distribution logistics and compliance with federal pharmaceutical standards. Key requirements for this contract include adherence to stringent manufacturing practices as outlined for pharmaceutical preparations, ensuring product quality, safety, and efficacy. The contractor is expected to deliver Azithromycin Tablets that meet all applicable regulatory and contractual specifications, supporting the DLA’s mission to provide essential medical supplies to military personnel and other federal beneficiaries. The contracting activity is managed by DLA Troop Support, a federal office within the Defense Logistics Agency. For further information or contract administration matters, the primary point of contact is Ryan Ferry ([email protected], 215-737-3182), with Jason Wray ([email protected], 215-737-0614) serving as the secondary contact. This award notice is currently active and was posted on February 24, 2026. Interested parties can access additional details and attachments related to the contract via the official SAM.gov opportunity page at https://sam.gov/opp/888142865d7e4d59a61f850b0ecf45e7/view. Contractors evaluating this opportunity should note that it is a national-level contract for a high-priority pharmaceutical product, requiring robust manufacturing capabilities, compliance with federal regulations, and the capacity to deliver consistent quality over the contract lifecycle. No specific set-aside requirements or special considerations are indicated in the notice. The contract is expected to remain stable in its core requirements, focusing on the sustained supply of Azithromycin Tablets to meet federal needs.